WHITEHAWK THERAPEUTICS, INC. Defined Contribution Plan, Cost
WHITEHAWK THERAPEUTICS, INC. (WHWK) reported Defined Contribution Plan, Cost of $400.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-12.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:DefinedContributionPlanCostRecognized · last filed 2026-03-12
- WHITEHAWK THERAPEUTICS, INC. defined contribution plan, cost for fiscal 2025 was $400.00K, a 33.33% decline from fiscal 2024.
- WHITEHAWK THERAPEUTICS, INC. defined contribution plan, cost for fiscal 2024 was $600.00K, a 14.29% decline from fiscal 2023.
- WHITEHAWK THERAPEUTICS, INC. defined contribution plan, cost for fiscal 2023 was $700.00K, a 40.00% increase from fiscal 2022.
- WHITEHAWK THERAPEUTICS, INC. defined contribution plan, cost for fiscal 2022 was $500.00K.
| Period end | Defined Contribution Plan, Cost 12 month |
|---|---|
| 2025-12-31 | $400.00K 10-K · filed 2026-03-12 |
| 2024-12-31 | $600.00K 10-K · filed 2026-03-12 |
| 2023-12-31 | $700.00K 10-K · filed 2025-03-28 |
| 2022-12-31 | $500.00K 10-K · filed 2024-03-13 |
| 2021-12-31 | $0.00 10-K · filed 2023-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |